Skip to main content
    O

    Omeros Corporation (OMER)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $13.92
    -2.76 (-16.55%)

    Market Cap: $1.21B

    Last updated: Nov 17, 2026 at 4:36 PM ET

    Omeros Corporation (OMER) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Omeros (OMER) has a market cap of $1.21B and an enterprise value of $1.24B. It kept 126.23% of revenue as net income over the last 12 months. Its share count is up 10.14% from a year earlier.

    Total Valuation

    Enterprise value is 2.40% above the market cap, as debt exceeds cash.

    Market Cap$1.21B
    Enterprise Value$1.24B
    Latest price (Nov 17, 2026)$13.92

    Key Dates

    The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 29, 2027 (expected)
    Last Earnings DateNov 16, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.18% in the quarter ended Sep 30, 2026 and grew 12.22% a year over 2 years.

    Shares Outstanding72.98M
    Shares Change (YoY)+10.14%
    Shares Change (QoQ)+1.18%
    Share Count Growth (2Y CAGR)+12.22%

    Valuation Ratios

    The price to sales ratio is 13.7x.

    P/E Ratio134.4x
    Forward P/E16.5x
    P/S Ratio13.7x
    Forward P/S9.5x

    Valuation history and multiples

    Enterprise Valuation

    EV / Earnings13.2x
    EV / Sales16.6x

    Price Statistics

    The stock is up 76.87% over 52 weeks and trades 23.18% below its 50-day average.

    Beta (1Y)1.72
    52-Week Change+76.87%
    1-Month Change-14.86%
    3-Month Change-24.31%
    6-Month Change+16.29%
    5-Year Change+194.10%
    10-Year Change+124.88%
    Total Return (1Y)+76.87%
    Total Return (3Y CAGR)+103.95%
    Total Return (5Y CAGR)+12.41%
    Return vs SPY (1Y)+52.21%
    Max Drawdown (1Y)-49.52%
    Max Drawdown (3Y)-75.56%
    Sharpe Ratio (1Y)0.52
    Correlation with SPY (1Y)0.25
    50-Day Average$18.12
    200-Day Average$13.80
    52-Week Range$6.70 to $21.24
    RSI (14 Days)30.8
    Average Volume (20 Days)1.22M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.27x current liabilities.

    Current Ratio2.27x
    Quick Ratio2.26x
    Interest Coverage-1.27x

    Returns and Efficiency

    Return on invested capital is 33.61% over the last 12 months.

    Return on Assets (ROA)37.83%
    Return on Invested Capital (ROIC)33.61%
    ROA (5Y Average)-6.88%
    Asset Turnover0.34x
    Inventory Turnover3.41x
    Receivables Turnover3.35x
    Cash Conversion Cycle-712 days

    Taxes

    Income tax took 0.18% of pretax income over the last 12 months.

    Income Tax (TTM)$132.00K
    Effective Tax Rate0.18%

    Scores

    OMER has an Altman Z-Score of -2.84, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score-2.84
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $74.36M over the last 12 months.

    Revenue$74.36M
    Operating Income-$41.93M
    Pretax Income$74.62M
    Net Income$93.86M
    Reported EPS (TTM)$0.10

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$5.07M
    Total Debt$34.04M
    Net Debt$28.97M
    Net Debt Per Share$0.40
    Working Capital$84.32M
    Shareholder Equity-$89.97M
    Total Assets$248.09M
    Total Liabilities$338.07M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $70.00K of capital spending, operating cash flow left -$37.01M of free cash flow.

    Operating Cash Flow-$36.94M
    Capital Expenditures$70.00K
    Free Cash Flow-$37.01M
    FCF Per Share-$0.51
    Depreciation and Amortization$9.57M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -56.39%.

    Operating Margin-56.39%
    Pretax Margin100.36%
    Net Margin126.23%
    FCF Margin-49.78%

    Dividends and Yields

    OMER does not pay a dividend. Its free cash flow yield is -3.64%.

    Earnings Yield0.74%
    FCF Yield-3.64%
    Buyback Yield0.61%
    Shareholder Yield0.61%

    Peer Position

    Against 6 similar companies, OMER has the 4th highest P/S.

    P/S Ratio13.7x vs 9.7x median
    ROIC33.61% vs -34.79% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About OMER

    What is OMER's market cap?

    Omeros has a market cap of $1.21B. Its enterprise value, which adds debt and subtracts cash, is $1.24B.

    What is OMER's P/E ratio?

    Omeros has a trailing P/E ratio of 134.4x and a forward P/E of 16.5x.

    How many shares of OMER are outstanding?

    Omeros has 72.98M shares outstanding. The count is up 10.14% from a year earlier.

    Does OMER pay a dividend?

    No. Omeros does not pay a dividend.

    How much debt does OMER have?

    Omeros has $34.04M of total debt and $5.07M of cash and equivalents, a net debt position of $28.97M.